Watch this CME-certified on-demand Webcast of a CCO symposium at AMCP 2019 to gain expert pharmacist and oncologist perspectives on the evolving role of EGFR TKIs in EGFR-mutated NSCLC, including EGFR TKI pharmacology, selecting optimal treatment across the disease course based on the latest clinical data, cost and access considerations, and a panel discussion.
Download this slideset to review the landscape of EGFR mutations in advanced NSCLC and the pharmacology of EGFR tyrosine kinase inhibitors used in this setting.
Download this slideset to get up to date on the latest first-line and second-line clinical data in the setting of EGFR mutation–positive NSCLC.
Download this slideset to gain pharmacy perspectives in the delivery of care to patients with EGFR-mutated NSCLC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.